Saliva versus Blood Therapeutic Drug Monitoring of Tacrolimus in Jordanian Kidney Transplant Patients

Salim Hamadi, Fathia Banna, Nasir Idkaidek, Izzat Al-Awwa and Ahmad Al-Ghazawi
Additional contact information
Nasir Idkaidek: University of Petra, College of Pharmacy, Jordan
Izzat Al-Awwa: Jordan university hospital, Amman, Jordan
Ahmad Al-Ghazawi: Triumpahrma LLC, Amman, Jordan

Novel Approaches in Drug Designing & Development, 2018, vol. 4, issue 2, 33-37

Abstract: Tacrolimus is a macrolide antibiotic with immunosuppressive properties, it is indicated as primary immunosuppressive therapy following liver, heart and kidney transplantation, because of its better survival results and less acute cellular rejection than cyclosporine. The main objectives of this study are to investigate the robustness of using a non- invasive saliva sampling method instead of a blood sampling method as a surrogate for therapeutic drug monitoring (TDM) of tacrolimus among Jordanian patients, develop validated, sensitive and specific method (LC-MS/MS) for determination of tacrolimus in blood and saliva, determine the correlation between blood tacrolimus concentration versus saliva tacrolimus concentration and determine the variability in pharmacokinetic parameters of tacrolimus among patients to individualize dosage regimen. Forty two patients participated in this study. Two samples were collected from each patient two hours before morning dose, one sample is blood, and another is resting saliva sample.

Keywords: juniper publishers; drug designing pdf; drug designing articles; drug designing abstract; drug designing journal; modern approaches in drug designing journal; drug designing & intellectual properties international journal; peer reviewed open access journals; high impact journals; juniper publishers review (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/napdd/pdf/NAPDD.MS.ID.555632.pdf (application/pdf)
https://juniperpublishers.com/napdd/NAPDD.MS.ID.555632.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jnapdd:v:4:y:2018:i:2:p:33-37

DOI: 10.19080/NAPDD.2018.04.555632

Access Statistics for this article

Novel Approaches in Drug Designing & Development is currently edited by Sophia Mathis

More articles in Novel Approaches in Drug Designing & Development from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().